Physician profile
Mohammad Ghazi Moghadam
NPI 1023183746
$846.19
in general payments reported to CMS, 2019-2025
8 companies · $84.24 in 2025
The $84.24 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.47 · 2021: $45.10 · 2022: $253 · 2023: $247 · 2024: $130 · 2025: $84.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.89 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $436.47 | 2019-2025 | Xtandi, Myrbetriq |
| Teleflex LLC | $212.04 | 2023-2024 | Urolift |
| Merck Sharp & Dohme LLC | $44.00 | 2022 | |
| Antares Pharma, INC. | $43.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $43.55 | 2025 | |
| Janssen Biotech, INC. | $30.58 | 2019 | |
| Telix Pharmaceuticals | $19.20 | 2025 | |
| Urogen Pharma, INC. | $16.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Ghazi Moghadam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.